Skip to main content
. 2020 Jul 1;16(3):438–447. doi: 10.3988/jcn.2020.16.3.438

Table 1. Basic information on the study subjects.

Variable Total Prognosis Statistical value p
Good (n=23) Poor (n=37)
Age, years 25 [20–35] 22 [16–28] 27 [21–36] -2.048* 0.041
Sex
 Male 24 (40.0) 10 (43.5) 14 (37.8) 0.188 0.665
 Female 36 (60.0) 13 (56.5) 23 (62.2)
Initial symptoms - 0.352
 Mental behavioral disorders/cognitive dysfunction 34 (56.7) 11 (47.8) 23 (62.2)
 Speech disorders 0 (0.0) 0 (0.0) 0 (0.0)
 Seizures 19 (31.6) 9 (39.1) 10 (27.0)
 Movement disorders/involuntary movement 0 (0.0) 0 (0.0) 0 (0.0)
 Disturbance of consciousness 1 (1.7) 0 (0.0) 1 (2.7)
 Autonomic dysfunction 0 (0.0) 0 (0.0) 0 (0.0)
Complicated with tumors 6 (10.0) 0 (0.0) 6 (16.2) - 0.073
Disturbance of consciousness 31 (51.7) 6 (26.1) 25 (67.6) 9.773 0.002
Immunotherapy 58 (96.7) 23 (100.0) 35 (94.6) - 0.519
Admission to neurology intensive care unit 46 (76.7) 14 (60.9) 32 (86.5) 5.203 0.023
Mechanical ventilation 16 (26.7) 2 (8.7) 14 (37.8) 6.160 0.013

Data are median [interquartile range] or n (%) values.

*Z value in the Mann-Whitney U-test, χ2, p value in Fisher's exact test.